It is a business services private limited company based in Mumbai, Maharashtra, India, established in 2025.
2025 | Mumbai, Maharashtra, India | ActiveInlex Pharmaceutical Private Limited, a active private limited company, was established on 10 March 2025 in Mumbai, Maharashtra, India. it holds CIN: U47721MH2025PTC442714. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Its leadership includes Brijesh Kumar Pathak (Director), Sannu Brijesh Pathak (Director). It is based at Room No-29 Near Shanti, Ind Vishwashanti Nagar, Mumbai, Maharashtra, 400080.
U47721MH2025PTC442714
442714
10 March 2025
₹0.10 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Inlex Pharmaceutical Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Brijesh Kumar Pathak | Director | 10 Mar 2025 | Current |
| Sannu Brijesh Pathak | Director | 10 Mar 2025 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Inlex Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Inlex Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Inlex Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Inlex Pharmaceutical's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Brijesh Kumar Pathak was appointed as a Director was appointed as a Director on 10 Mar 2025 & has been associated with this company since 8 months 16 days . was completed.
Sannu Brijesh Pathak was appointed as a Director was appointed as a Director on 10 Mar 2025 & has been associated with this company since 8 months 16 days . was recorded as a recent event.
Progress on Inlex Pharmaceutical Private Limited was registered on 10 Mar 2025 with Roc Mumbai & aged 8 months 16 days as per MCA records. was documented.
The CIN of Inlex Pharmaceutical Private Limited is U47721MH2025PTC442714.
Inlex Pharmaceutical Private Limited is headquartered at Room No-29 Near Shanti, Ind Vishwashanti Nagar, Mumbai, Maharashtra, 400080.
Inlex Pharmaceutical Private Limited was incorporated on 10 March 2025.
The current directors of Inlex Pharmaceutical Private Limited are
Inlex Pharmaceutical Private Limited is unlisted.
The authorized capital of Inlex Pharmaceutical Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX